Wadmalaw Island, SC, United States of America

Christopher C Lindsey

USPTO Granted Patents = 11 (Patent Applications = 1)

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

11 out of 173

Musc Foundation for Research Development

patents

2 out of 889

The United States Government As Represented by the Department of Veterans Affairs

patents

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

11 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11939301 - 5HT1F receptor agonists and mitochondrial biogenesis (2024-03-26),

2. 11014892 - 5HT1F receptor agonists and mitochondrial biogenesis (2021-05-25),

3. 10456400 - Aza-ellipticine analogs, methods of synthesis and methods of treatment (2019-10-29),

4. 10370328 - Oxindole compounds and pharmaceutical compositions thereof (2019-08-06),

5. 9981994 - Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders (2018-05-29),

6. 9970947 - Fluorescent probe (2018-05-15),

7. 9920029 - Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders (2018-03-20),

8. 9850218 - Thiazole compounds, compositions and methods for treatment of degenerative diseases and disorders (2017-12-26),

9. 9556207 - Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders (2017-01-31),

10. 9079853 - Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders (2015-07-14),

11. 8921401 - Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders (2014-12-30),

Title: Christopher C. Lindsey: Innovator in Mitochondrial Biogenesis

Introduction

Christopher C. Lindsey is an accomplished inventor based in Wadmalaw Island, SC. With a remarkable portfolio that includes 11 patents, Lindsey is recognized for his contributions to the field of pharmaceutical innovations, particularly in the area of mitochondrial biogenesis.

Latest Patents

Among his latest inventions are groundbreaking compounds known as 5HT1F receptor agonists, which have been specifically designed to promote mitochondrial biogenesis. These compounds are formulated to assist in the treatment of conditions such as acute kidney injury and chronic kidney disease, showcasing Lindsey's commitment to addressing pressing medical challenges through innovative solutions.

Career Highlights

Lindsey has made significant contributions during his tenure at prominent organizations such as the Musc Foundation for Research Development and the United States Government, represented by the Department of Veterans Affairs. His work in these institutions has paved the way for advancements in healthcare and treatment methodologies.

Collaborations

Throughout his career, Lindsey has collaborated with esteemed professionals, including Craig C. Beeson and Yuri Karl Peterson. These partnerships have fostered a creative environment that has led to the development of innovative solutions in the medical sector.

Conclusion

As an inventor, Christopher C. Lindsey exemplifies the spirit of innovation through his dedicated research and development in the field of mitochondrial biogenesis. His inventions not only reflect his expertise but also hold the potential to significantly impact patient care and treatment strategies in the future.

This text is generated by artificial intelligence and may not be accurate.